Live feed
·
INSIDERFilingvia Quantisnow
Viridian Therapeutics Inc. logo

Chief Operating Officer Beetham Thomas W. converted options into 9,409 shares and covered exercise/tax liability with 3,138 shares, increasing direct ownership by 90% to 13,271 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VRDN (Viridian Therapeutics Inc.) and more on Quantisnow.